Latest Welcure Drugs & Pharmaceuticals stock price
Welcure Drugs & Pharmaceuticals P/E Ratio
WELCURE • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
1.1
Low Valuation
Very Low - Potentially undervalued or facing challenges
Current Valuation Metrics
P/E Ratio
1.1
Current Price
₹0.30
EPS (TTM)
₹0.36
Exchange
BSE
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
48.43
Sector Median
27.37
Sector Rank
#1 of 139
Sector Percentile
0.7%
Key P/E Ratio Insights for Welcure Drugs & Pharmaceuticals
- Stock appears undervalued with PE of 1.1, suggesting potential buying opportunity
- Trading at discount to sector average PE of 48.43
View the WELCURE equity price for detailed stock performance.
Related Pages for Welcure Drugs & Pharmaceuticals
Additional stock information and data for WELCURE
Sector P/E Ratio Comparison
Comparing Welcure Drugs & Pharmaceuticals with other companies in Healthcare sector
Sector Average
48.43
Sector Median
27.37
Lowest P/E
3.14
Highest P/E
754.17
Companies
139
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 3.14 | ₹47 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.87 | ₹1,186 | Low |
| Amwill Health Care | AMWILL | 6.5 | ₹67 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹27 | Low |
| JFL Life Sciences | JFLLIFE | 7.53 | ₹36 | Low |
| Galaxy Medicare | GML | 7.66 | ₹26 | Low |
| Unichem Laboratories | UNICHEMLAB | 8.42 | ₹2,437 | Low |
| Zenith Drugs | ZENITHDRUG | 9.03 | ₹85 | Low |
| Brooks Laboratories | BROOKS | 9.44 | ₹198 | Low |
| Vasundhara Rasayans | VRL | 10.96 | ₹41 | Low |